A case of pancreatic neuroendocrine tumors

被引:0
作者
Masato Moriyama
Yoshifumi Matsumoto
Qiliang Zhou
Kanako Yamana
Yohei Ikeda
Fumio Ayukawa
Eisuke Abe
Seijiro Sato
Kabuto Takano
Motoki Kaidu
Hidefumi Aoyama
Yasuo Saijo
机构
[1] Niigata University Graduate School of Medical and Dental Sciences,Department of Medical Oncology
[2] Niigata University Graduate School of Medical and Dental Sciences,Department of Radiology and Radiation Oncology
[3] Niigata University Graduate School of Medical and Dental Sciences,Department of Thoracic Surgery
[4] Niigata University Graduate School of Medical and Dental Sciences,Department of Digestive Surgery
关键词
Neuroendocrine tumor; Lung metastasis; Mediastinal lymph nodes swelling; Radiotherapy;
D O I
10.1007/s13691-015-0230-x
中图分类号
学科分类号
摘要
Pancreatic neuroendocrine tumors (pNETs) are an uncommon malignancy arising from the neuroendocrine cells of pancreas. Most cases of pNETs present with metastatic disease, but there are few reports in the literature describing pNETs metastasis to the lung and mediastinal lymph nodes [1]. Moreover, although a multimodal treatment including surgical resection and chemotherapy is acceptable for management of pNETs, advanced pNETs still remain a difficult therapeutic challenge [2, 3]. Radiotherapy or combined chemoradiotherapy has not been standard in the treatment of pNETs. An 80-year-old female was admitted to our hospital with cough and anorexia. She had been diagnosed and resected pNETs 8 years ago. Mass shadow was pointed out with chest X-ray, and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) was performed. Pathological examination revealed neuroendocrine tumors, so the lung mass was considered as metastasis of pNETs. Then, we discussed her treatment at Cancer Board, and radiotherapy was chosen. We hope this case suggests that radiotherapy will be one of the treatment options for metastatic pNETs.
引用
收藏
页码:1 / 4
页数:3
相关论文
共 33 条
[1]  
Satahoo-Dawes S(2011)Breast and lung metastasis from pancreatic neuroendocrine carcinoma World J Radiol 3 32-37
[2]  
Palmer J(2012)Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs) Gut 61 6-32
[3]  
Iii EW(2013)Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours) Endokrynol Pol 64 418-443
[4]  
Ramage JK(2014)Update on pancreatic neuroendocrine tumors Gland Surg 3 258-275
[5]  
Ahmed A(2014)A single institution’s 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram Ann Surg 259 204-212
[6]  
Ardill J(2013)Role of radiotherapy for pancreatobiliary neuroendocrine tumors Radiat Oncol J 31 125-130
[7]  
Kos-Kudła B(2013)Neuroendocrine tumor metastatic to the orbit treated with radiotherapy World J Gastrointest Oncol 5 177-180
[8]  
Blicharz-Dorniak J(2012)Neuroendocrine carcinoma of the ethmoid sinuses treated with radiotherapy alone J Laryngol Otol 126 1066-1068
[9]  
Handkiewicz-Junak D(2010)Cancer: antitumor effects of octreotide LAR, a somatostatin analog Nat Rev Endocrinol 6 188-189
[10]  
McKenna LR(2014)Lanreotide in metastatic enteropancreatic neuroendocrine tumors N Engl J Med 371 224-233